Summary
Gilead Sciences, Inc. (GILD) announced its financial results for the quarter ended June 30, 2025, via a press release filed on August 7, 2025. This 8-K filing primarily serves to report these earnings, providing investors with an update on the company's operational and financial performance. The press release, attached as Exhibit 99.1, contains detailed financial information presented under both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures. Investors should note that while Gilead presents non-GAAP financial information to offer additional insights into its performance, it is crucial to review this alongside the official GAAP financial statements. The company emphasizes that non-GAAP measures are not standardized across the industry and provides a reconciliation of these figures to GAAP in the accompanying press release. This filing acts as a notification of earnings release, directing investors to the detailed information contained within Exhibit 99.1 for a comprehensive understanding of Gilead's quarterly results.
Key Highlights
- 1Gilead Sciences (GILD) filed an 8-K on August 7, 2025, reporting its financial results for the quarter ended June 30, 2025.
- 2The core of the filing is the press release (Exhibit 99.1) containing the company's quarterly financial performance.
- 3Gilead presented financial results using both GAAP and non-GAAP measures.
- 4Management believes non-GAAP information is useful for operational and financial planning and provides additional insights to investors.
- 5A reconciliation between GAAP and non-GAAP financial figures is available within the press release.
- 6Information within this 8-K and its exhibits is not considered 'filed' for Section 18 purposes and does not automatically incorporate by reference into other filings.
- 7Investors are directed to the press release (Exhibit 99.1) for detailed financial data and analysis.